These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23168212)

  • 1. A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature.
    Ragupathi L; Najfeld V; Chari A; Petersen B; Jagannath S; Mascarenhas J
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):175-9. PubMed ID: 23168212
    [No Abstract]   [Full Text] [Related]  

  • 2. Strange bedfellows: mitotically active chronic myeloid leukemia in molecular complete remission, detected in focal lesion of myeloma.
    Guru Murthy GS; Sawyer J; Alapat D; Samant R; Barlogie B
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e127-9. PubMed ID: 24685577
    [No Abstract]   [Full Text] [Related]  

  • 3. A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.
    Ahn S; Park JS; Han JH; Cho SR
    Ann Lab Med; 2015 May; 35(3):370-2. PubMed ID: 25932449
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of Myelofibrosis in Chronic Myeloid Leukemia, Multiple Myeloma, and Chronic Lymphoid Leukemia during Various Phases of Diseases.
    Dolgikh TY; Domnikova NP; Tornuev YV; Vinogradova EV; Krinitsyna YM
    Bull Exp Biol Med; 2017 Feb; 162(4):483-487. PubMed ID: 28239786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two siblings with chronic myelogenous leukemia.
    Kapsali E; Tsiara S; Christou L; Panteli A; Bourantas KL
    J Exp Clin Cancer Res; 2000 Dec; 19(4):541-3. PubMed ID: 11277336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked discordance between cytogenetic/molecular and morphologic findings in a patient with chronic myeloid leukemia.
    Rashidi A; Courville E
    Blood Cells Mol Dis; 2017 Mar; 63():32-33. PubMed ID: 28110131
    [No Abstract]   [Full Text] [Related]  

  • 7. Three patients with multiple myeloma developing secondary lymphoblastic leukemia: case reports and review of the literature.
    Junxun L; Junru L; Meilan C; Chujia L; Shaoqian C; Jieyu Z; Zhuangjian Y; Fan Z; Juan O; Jing C; Juan L
    Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26166219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The combination of chronic myeloid leukemia and multiple myeloma in one patient].
    Romanenko NA; Bessmel'tsev SS; Udal'eva VIu; Zenina MN; Martynkevich IS; Rugal' VI; Abdulkadyrov KM
    Vopr Onkol; 2013; 59(2):103-10. PubMed ID: 23814859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative-kinetic aspects of granulocytic resistance to infection in hematologic systemic diseases with reference to antineoplastic chemotherapy].
    Sommer S
    Z Arztl Fortbild (Jena); 1988; 82(11):513-5. PubMed ID: 3176536
    [No Abstract]   [Full Text] [Related]  

  • 10. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
    Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
    Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic myelogenous leukemia manifested as bilateral proliferative retinopathy.
    Mandava N; Costakos D; Bartlett HM
    Arch Ophthalmol; 2005 Apr; 123(4):576-7. PubMed ID: 15824241
    [No Abstract]   [Full Text] [Related]  

  • 12. Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.
    Isoda A; Nakahashi H; Hoshino T; Mitsui T; Yoshida Y
    Am J Hematol; 2007 Jun; 82(6):501-2. PubMed ID: 17301971
    [No Abstract]   [Full Text] [Related]  

  • 13. Kappa light chain myeloma with initial cutaneous involvement.
    Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
    Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
    [No Abstract]   [Full Text] [Related]  

  • 14. Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.
    Kata D; Mrówka-Kata K; Seweryn M; Pajak J; Najda J; Kyrcz-Krzemień S
    Leuk Res; 2010 Sep; 34(9):e229-31. PubMed ID: 20359744
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic myelogenous leukemia evolving after treatment of multiple myeloma.
    Wolleschak D; Heidel FH
    Blood; 2016 Jul; 128(1):146. PubMed ID: 28092869
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
    Galanopoulos A; Papadhimitriou SI; Kritikou-Griva E; Georgiakaki M; Anagnostopoulos NI
    Ann Hematol; 2009 Mar; 88(3):281-2. PubMed ID: 18726593
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple myeloma: a rare case in an 8-year-old child.
    Crusoe Ede Q; da Silva AM; Agareno J; Chauffaille Mde L; Bonfim C; Moraes Hungria VT
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):e31-3. PubMed ID: 25441111
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic myeloid leukemia as a second malignant neoplasm in a patient with medulloblastoma after treatment with chemotherapy and irradiation: a case report and review of the literature.
    Dhir N; Zaky W; Zomorodian T; Dhall G
    Pediatr Hematol Oncol; 2013 Feb; 30(1):28-9. PubMed ID: 23273112
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?
    D'Arena G; Gemei M; Luciano L; D'Auria F; Deaglio S; Statuto T; Bianchino G; Grieco V; Mansueto G; Guariglia R; Pietrantuono G; Martorelli MC; Villani O; Del Vecchio L; Musto P
    J Clin Oncol; 2012 Nov; 30(32):e327-30. PubMed ID: 23008321
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia.
    Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K
    Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.